Related Experiment Video

Updated: Jun 1, 2026

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells
09:05

In Vitro Differentiation of Human Mesenchymal Stem Cells into Functional Cardiomyocyte-like Cells

Published on: August 9, 2017

Stem cell induced cardiac regeneration: fusion/mitochondrial exchange and/or transdifferentiation?

Yao-Hua Song1, Kai Pinkernell, Eckhard Alt

  • 1Department of Molecular Pathology, Center for Stem Cell and Developmental Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell Cycle (Georgetown, Tex.)
|June 10, 2011
PubMed

Insights

Adult stem cell therapy shows promise for heart regeneration. Mechanisms like cell fusion and paracrine factors are being explored to understand how stem cells repair damaged heart tissue.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Adult stem cell therapy offers potential for myocardial regeneration.
  • Mechanisms underlying stem cell therapy benefits, including fusion, transdifferentiation, and paracrine signaling, require further elucidation.
  • Understanding these mechanisms is crucial for advancing stem cell-based cardiac repair.

Purpose of the Study:

  • To investigate the fate and cardiomyogenic potential of human adipose tissue-derived stem cells (hASCs) fused with cardiomyocytes.
  • To review current literature on stem cell-cardiomyocyte interactions, including fusion and content exchange, in myocardial regeneration.

Main Methods:

  • Co-culture of rat neonatal cardiomyocytes with lentivirus-transduced hASCs or pig bone marrow-derived mesenchymal stem cells (MSCs) expressing eGFP.
  • Treatment of hASCs with hemagglutinating virus of Japan (HVJ) to induce fusion with cardiomyocytes.
  • Analysis of cardiac-specific protein expression (Titin, MF20) in eGFP-positive cells.

Main Results:

  • Fused hASC-cardiomyocyte cells exhibited a cardiomyocyte phenotype, including spontaneous rhythmic contraction and action potential generation in vitro.
  • eGFP-positive cells (hASCs or MSCs) showed evidence of cardiac contractile proteins, suggesting a cardiomyogenic differentiation or reprogramming.
  • Previous studies indicate that co-culturing with apoptotic cells enhances myogenic conversion.

Conclusions:

  • Stem cell fusion and content exchange with cardiomyocytes may contribute to the reprogramming of differentiated cardiomyocytes.
  • Further research into stem cell-derived factors and fusion mechanisms is needed to optimize stem cell therapy for myocardial regeneration.
  • This review consolidates current understanding of stem cell interactions in cardiac repair.

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Related Concept Videos

Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.